Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126185151 | 12618515 | 1 | I | 201601 | 20160729 | 20160803 | 20160803 | EXP | RU-GLAXOSMITHKLINE-RU2016GSK110441 | GLAXOSMITHKLINE | 81.00 | YR | F | Y | 76.00000 | KG | 20160803 | MD | RU | RU |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126185151 | 12618515 | 1 | PS | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK | Y | U | 21254 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126185151 | 12618515 | 1 | Aspirin-exacerbated respiratory disease |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126185151 | 12618515 | OT |
126185151 | 12618515 | LT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126185151 | 12618515 | Asthenia | |
126185151 | 12618515 | Dyspnoea | |
126185151 | 12618515 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126185151 | 12618515 | 1 | 201601 | 201601 | 0 |